This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhang, Z.-F. Articles by Schantz, S. P. Search for Related Content PubMed PubMed Citation Articles by Zhang, Z.-F. Articles by Schantz, S. P.

Marijuana Use and Increased Risk of Squamous Cell Carcinoma of the Head and Neck¹

Department of Epidemiology, University of California at Los Angeles School of Public Health, and Jonsson Comprehensive Cancer Center, Los Angeles, California 90095-1772 [Z-F. Z., H. M.]; Departments of Epidemiology [M. R. S.] and Cell Biology [T. C. H.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030; Department of Medicine, University of California at Los Angeles School of Medicine, Los Angeles, California 90095 [D. P. T.]; New York Eye and Ear Infirmary, New York, New York 10003 [G-P. Y., S. P. S.]; and Arizona Cancer Center, Tucson, Arizona 85724 [J. R. M.]

Marijuana is the most commonly used illegal drug in the United States. In some subcultures, it is widely perceived to be harmless. Although the carcinogenic properties of marijuana smoke are similar to those of tobacco, no epidemiological studies of the relationship between marijuana use and head and neck cancer have been published. The relationship between marijuana use and head and neck cancer was investigated by a case-control study of 173 previously untreated cases with pathologically confirmed diagnoses of squamous cell carcinoma of the head and neck and 176 cancer-free controls at Memorial Sloan-Kettering Cancer Center between 1992 and 1994. Epidemiological data were collected by using a structured questionnaire, which included history of tobacco smoking, alcohol use, and marijuana use. The associations between marijuana use and head and neck cancer were analyzed by Mantel-Haenszel methods and logistic regression models. Controlling for age, sex, race, education, alcohol consumption, pack-years of cigarette smoking, and passive smoking, the risk of squamous cell carcinoma of the head and neck was increased with marijuana use [odds ratio (OR) comparing ever with never users, 2.6; 95% confidence interval (CI), 1.1–6.6]. Dose-response relationships were observed for frequency of marijuana use/day (P for trend < 0.05) and years of marijuana use (P for trend < 0.05). These associations were stronger for subjects who were 55 years of age and younger (OR, 3.1; 95% CI, 1.0–9.7). Possible interaction effects of marijuana use were observed with cigarette smoking, mutagen sensitivity, and to a lesser extent, alcohol use. Our results suggest that marijuana use may increase the risk of head and neck cancer with a strong dose-response pattern. Our analysis indicated that marijuana use may interact with mutagen sensitivity and other risk factors to increase the risk of head and neck cancer. The results need to be interpreted with some caution in drawing causal inferences because of certain methodological limitations, especially with regard to interactions.

This article has been cited by other articles:

				M. L. Gillison, G. D'Souza, W. Westra, E. Sugar, W. Xiao, S. Begum, and R. Viscidi Distinct Risk Factor Profiles for Human Papillomavirus Type 16-Positive and Human Papillomavirus Type 16-Negative Head and Neck Cancers J Natl Cancer Inst, March 19, 2008; 100(6): 407 - 420. [Abstract] [Full Text] [PDF]

				M. J. Seamon, J. A. Fass, M. Maniscalco-Feichtl, and N. A. Abu-Shraie Medical marijuana and the developing role of the pharmacist Am. J. Health Syst. Pharm., May 15, 2007; 64(10): 1037 - 1044. [Abstract] [Full Text] [PDF]

				M. Hashibe, H. Morgenstern, Y. Cui, D. P. Tashkin, Z.-F. Zhang, W. Cozen, T. M. Mack, and S. Greenland Marijuana use and the risk of lung and upper aerodigestive tract cancers: results of a population-based case-control study. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1829 - 1834. [Abstract] [Full Text] [PDF]

				P. Pacher, S. Batkai, and G. Kunos The Endocannabinoid System as an Emerging Target of Pharmacotherapy Pharmacol. Rev., September 1, 2006; 58(3): 389 - 462. [Abstract] [Full Text] [PDF]

				F. A. de Jong, F. K. Engels, R. H.J. Mathijssen, L. van Zuylen, J. Verweij, R. P.H. Peters, and A. Sparreboom Medicinal Cannabis in Oncology Practice: Still a Bridge Too Far? J. Clin. Oncol., May 1, 2005; 23(13): 2886 - 2891. [Full Text] [PDF]

				R. J. McKallip, M. Nagarkatti, and P. S. Nagarkatti {Delta}-9-Tetrahydrocannabinol Enhances Breast Cancer Growth and Metastasis by Suppression of the Antitumor Immune Response J. Immunol., March 15, 2005; 174(6): 3281 - 3289. [Abstract] [Full Text] [PDF]

				K. A. Rosenblatt, J. R. Daling, C. Chen, K. J. Sherman, and S. M. Schwartz Marijuana Use and Risk of Oral Squamous Cell Carcinoma Cancer Res., June 1, 2004; 64(11): 4049 - 4054. [Abstract] [Full Text] [PDF]

				W. M. Compton, B. F. Grant, J. D. Colliver, M. D. Glantz, and F. S. Stinson Prevalence of Marijuana Use Disorders in the United States: 1991-1992 and 2001-2002 JAMA, May 5, 2004; 291(17): 2114 - 2121. [Abstract] [Full Text] [PDF]

				T. W. Klein, C. Newton, K. Larsen, L. Lu, I. Perkins, L. Nong, and H. Friedman The cannabinoid system and immune modulation J. Leukoc. Biol., October 1, 2003; 74(4): 486 - 496. [Abstract] [Full Text] [PDF]

				B. W. Neville and T. A. Day Oral Cancer and Precancerous Lesions CA Cancer J Clin, July 1, 2002; 52(4): 195 - 215. [Abstract] [Full Text] [PDF]

				S. P. Schantz and G.-P. Yu Head and Neck Cancer Incidence Trends in Young Americans, 1973-1997, With a Special Analysis for Tongue Cancer Arch Otolaryngol Head Neck Surg, March 1, 2002; 128(3): 268 - 274. [Abstract] [Full Text] [PDF]

				S. SILVERMAN JR Demographics and occurrence of oral and pharyngeal cancers: The outcomes, the trends, the challenge J Am Dent Assoc, November 1, 2001; 132(suppl_1): 7S - 11S. [Abstract] [Full Text] [PDF]

				M. D. Roth, J. A. Marques-Magallanes, M. Yuan, W. Sun, D. P. Tashkin, and O. Hankinson Induction and Regulation of the Carcinogen-Metabolizing Enzyme CYP1A1 by Marijuana Smoke and Delta 9-Tetrahydrocannabinol Am. J. Respir. Cell Mol. Biol., March 1, 2001; 24(3): 339 - 344. [Abstract] [Full Text] [PDF]

				Z.-F. Zhang, H. Morgenstern, M. R. Spitz, D. P. Tashkin, G.-P. Yu, T. C. Hsu, and S. P. Schantz Environmental Tobacco Smoking, Mutagen Sensitivity, and Head and Neck Squamous Cell Carcinoma Cancer Epidemiol. Biomarkers Prev., October 1, 2000; 9(10): 1043 - 1049. [Abstract] [Full Text]

				L. X. Zhu, S. Sharma, M. Stolina, B. Gardner, M. D. Roth, D. P. Tashkin, and S. M. Dubinett {Delta}-9-Tetrahydrocannabinol Inhibits Antitumor Immunity by a CB2 Receptor-Mediated, Cytokine-Dependent Pathway J. Immunol., July 1, 2000; 165(1): 373 - 380. [Abstract] [Full Text] [PDF]

				The cannabis policy debate: finding a way forward Can. Med. Assoc. J., June 1, 2000; 162(12): 1690 - 1692.

				S. E. Straus Immunoactive cannabinoids: Therapeutic prospects for marijuana constituents PNAS, August 15, 2000; 97(17): 9363 - 9364. [Full Text] [PDF]